EyeGene Inc. (KOSDAQ:185490)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,480.00
-25.00 (-1.66%)
At close: Jun 5, 2026

EyeGene Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
63,98075,17769,19691,605108,036408,921
Market Cap Growth
-24.26%8.64%-24.46%-15.21%-73.58%175.32%
Enterprise Value
21,84951,68238,54252,91941,816313,462
Last Close Price
1480.001739.002190.983650.204304.9316346.74
PS Ratio
15.9121.0820.6229.3120.41126.13
PB Ratio
1.211.341.321.401.574.60
P/TBV Ratio
1.251.391.501.471.644.64
EV/Sales Ratio
5.4314.4911.4916.937.9096.68
Debt / Equity Ratio
0.010.010.050.030.040.04
Net Debt / Equity Ratio
-0.78-0.80-0.57-0.81-0.93-0.91
Net Debt / EBITDA Ratio
4.595.722.762.132.812.40
Net Debt / FCF Ratio
4.807.392.202.483.312.51
Asset Turnover
0.060.050.050.040.060.04
Inventory Turnover
4.383.716.904.564.102.40
Quick Ratio
5.325.743.646.8113.798.99
Current Ratio
5.465.893.756.8813.999.23
Return on Equity (ROE)
-38.34%-35.14%-21.89%-33.39%-33.55%-67.87%
Return on Assets (ROA)
-10.73%-9.31%-11.55%-21.36%-16.24%-29.28%
Return on Capital Employed (ROCE)
-19.40%-16.60%-23.70%-38.80%-31.90%-36.70%
Earnings Yield
-25.35%-20.89%-17.53%-23.04%-24.02%-8.45%
FCF Yield
-13.40%-8.09%-19.78%-23.48%-17.90%-7.92%
Buyback Yield / Dilution
-18.73%-3.52%-24.79%-0.94%-13.22%-36.98%